Strong interim results with 27% normalized operating profit growth and 34% higher headline earnings, driven by robust performances across banking, health, life, and global segments. Cash conversion remains high, leverage is declining, and the group is well positioned for continued growth and resilience.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.